Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells.

Published on Mar 1, 2019in Biomedicine & Pharmacotherapy6.53
· DOI :10.1016/J.BIOPHA.2018.12.055
Poonam Yadav1
Estimated H-index: 1
(HBNI: Homi Bhabha National Institute),
Bhavani S. Shankar12
Estimated H-index: 12
(HBNI: Homi Bhabha National Institute)
Sources
Abstract
Abstract Aims A major obstacle for effective cancer treatment by radiation therapy is the development of radio-resistance and identification of underlying mechanisms and activated pathways will lead to better combination therapies. Main methods Irradiated MCF-7 and MDA-MB-231 breast cancer cell lines were characterised following different recovery periods. Proliferation was assessed by MTT, BrdU and clonogenic assays and apoptosis by Annexin V/ propidium iodide staining and flow cytometry. Gene expression was monitored by real time PCR/ELISA/antibody labelling and migration using transwell inserts. Key findings Breast cancer cell lines exposed to 6 Gy followed by recovery period for 7 days (D7-6 G) had increased ability for proliferation as well as apoptosis. D7-6 G from both cell lines had increased expression of transforming growth factor isoforms (TGF)-β1, β2 and β3, their receptors TGF-βR1 and TGF-βR2 which are known for such dual effects. The expression of downstream transcription factors Snail, Zeb-1 and HMGA2 also showed a differential pattern in D7-6 G cells with upregulation of at least two of these transcription factors. D7-6 G cells from both cell lines displayed hybrid epithelial-mesenchymal (E/M) phenotype with increased expression of E/M markers and migration. D7-6 G cells had increased expression of cancer stem cells markers Oct4, Sox2, and Nanog; aldehyde dehydrogenase expression and activity; proportion of CD44+CD24−cells. This was accompanied by radio resistance when exposed to a challenge dose of radiation. Treatment with TGF-βRI inhibitor abrogated the increase in proliferation of D7-6 G cells. Significance Blocking of TGF-β signalling may therefore be an effective strategy for overcoming radio resistance induced by radiation exposure.
📖 Papers frequently viewed together
2007
12 Authors (Hiroki Takahashi)
References57
Newest
#1Valentina Fustaino (National Research Council)H-Index: 4
#2Dario Presutti (National Research Council)H-Index: 6
Last. Giovina Ruberti (National Research Council)H-Index: 22
view all 9 authors...
// Valentina Fustaino 1, 2, * , Dario Presutti 1, * , Teresa Colombo 2 , Beatrice Cardinali 1 , Giuliana Papoff 1 , Rossella Brandi 3 , Paola Bertolazzi 4, 2 , Giovanni Felici 2, ** and Giovina Ruberti 1, ** 1 Institute of Cell Biology and Neurobiology, National Research Council (IBCN-CNR), Monterotondo, Rome, Italy 2 Institute for Systems Analysis and Computer Science “Antonio Ruberti” National Research Council, (IASI-CNR), Rome, Italy 3 Genomics facility of the European Brain Research Institut...
Source
#1Yanwei Lu (HUST: Huazhong University of Science and Technology)H-Index: 7
#2Jia Ma (HUST: Huazhong University of Science and Technology)H-Index: 4
Last. Shuangbing Xu (HUST: Huazhong University of Science and Technology)H-Index: 9
view all 11 authors...
CDP138 silencing inhibits TGF- β /Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer
Source
#1Lingjian Yang (MAHSC: Manchester Academic Health Science Centre)H-Index: 9
#2Janet Taylor (MAHSC: Manchester Academic Health Science Centre)H-Index: 8
Last. Catharine M L West (MAHSC: Manchester Academic Health Science Centre)H-Index: 78
view all 11 authors...
Purpose: Hypoxia modification improves overall survival in muscle-invasive bladder cancer patients who undergo radiotherapy. There is evidence that hypoxic tumors benefit most from hypoxia modification. The study aimed to identify or derive a hypoxia gene signature that predicts benefit from hypoxia-modifying treatment in bladder cancer. Experimental Design: Published hypoxia signatures were tested and a new one derived by analyzing bladder cancer transcriptomic data from public databases. Tumor...
Source
#1Qingming GuoH-Index: 4
#2Danni ZhuH-Index: 3
Last. Peng ZhaoH-Index: 5
view all 9 authors...
Recurrence of breast cancer after radiotherapy may be partly explained by the presence of radioresistant cells. Thus, it would be desirable to develop an effective therapy against radioresistant cells. In this study, we demonstrated the intense antitumor activity of cytokine-induced killer cells against MCF-7 and radioresistant MCF-7 cells, as revealed by cytokine-induced killer–mediated cytotoxicity, tumor cell proliferation, and tumor invasion. Radioresistant MCF-7 cells were more susceptible ...
Source
#1Ming Luo (SYSU: Sun Yat-sen University)H-Index: 1
#2Ling Ding (SYSU: Sun Yat-sen University)H-Index: 1
Last. Herui Yao (SYSU: Sun Yat-sen University)H-Index: 1
view all 4 authors...
Background A large proportion of breast cancer patients are resistant to radiotherapy, which is a mainstay treatment for this malignancy, but the mechanisms of radioresistance remain unclear.
Source
#1Athanasia Pavlopoulou (Academy of Athens)H-Index: 19
#2Yavuz Oktay (Dokuz Eylül University)H-Index: 11
Last. Alexandros G. Georgakilas (NTUA: National Technical University of Athens)H-Index: 52
view all 6 authors...
Breast cancer cells are suggested to be organized in a hierarchical manner with a subpopulation of stem cells, termed as breast cancer stem cells (BCSCs), which contribute significantly to tumorigenesis, cancer recurrence and metastasis. BCSCs have been demonstrated to exhibit significant resistance to conventional chemo- and radiotherapy. Recent evidence suggests that treatment of breast cancers with radiation or chemotherapy agents induces stem cell-like properties in non-stem cells. Herein, w...
Source
#1Yao Zhang (Shanxi Medical University)H-Index: 4
#2Jinzhi Lai (Case Western Reserve University)H-Index: 2
Last. Junran Zhang (Case Western Reserve University)H-Index: 28
view all 13 authors...
// Yao Zhang 1, 2, * , Jinzhi Lai 1, * , Zhanwen Du 1 , Jinnan Gao 2 , Shuming Yang 3 , Shashank Gorityala 4 , Xiahui Xiong 1 , Ou Deng 1, 5 , Zhefu Ma 5 , Chunhong Yan 6 , Gonzalo Susana 7 , Yan Xu 3, 4 , Junran Zhang 1 1 Department of Radiation Oncology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA 2 Department of Breast Surgery, Shanxi Academy of Medical Sciences, The Affiliated Shanxi Dayi Hospital of Shanxi Medical University, Shanxi, 030032, PR China 3 Case...
Source
#1Mohit Kumar Jolly (Rice University)H-Index: 43
Last. Herbert Levine (Rice University)H-Index: 90
view all 10 authors...
// Mohit Kumar Jolly 1,2 , Satyendra C. Tripathi 8,* , Dongya Jia 1,5,* , Steven M. Mooney 7 , Muge Celiktas 8 , Samir M. Hanash 8,10 , Sendurai A. Mani 9,11 , Kenneth J. Pienta 12 , Eshel Ben-Jacob 1,5,6,** and Herbert Levine 1,2,3,4 1 Center for Theoretical Biological Physics, Rice University, Houston, TX, USA 2 Department of Bioengineering, Rice University, Houston, TX, USA 3 Department of Physics and Astronomy, Rice University, Houston, TX, USA 4 Department of Biosciences, Rice University, H...
Source
#1Siobhan K. O’Brien (Pfizer)H-Index: 2
#2Liang Chen (Pfizer)H-Index: 2
Last. Marc Damelin (Pfizer)H-Index: 9
view all 8 authors...
Intratumoral heterogeneity helps drive the selection for diverse therapy-resistant cell populations. In this study, we demonstrate the co-existence of two therapy-resistant populations with distinct properties that are reproducibly enriched under conditions that characterize tumor pathophysiology. Breast cancer cells that survived chemotherapy or hypoxia were enriched for cells expressing the major hyaluronic acid receptor CD44. However, only CD44hi cells that survived chemotherapy exhibited can...
Source
#1Sha-sha Wang (Sichuan University)H-Index: 15
#2Jian Jiang (Sichuan University)H-Index: 15
Last. Ya-ling Tang (Sichuan University)H-Index: 25
view all 4 authors...
The epithelial–mesenchymal transition (EMT) has been reported to be an important program that is often activated during the process of cancer invasion and metastasis. Cancer stem cells (CSCs) that can initiate and maintain cancer are also involved in invasion and metastasis of cancer. Recently, insights into the molecular mechanisms and functional features of mesenchymal cells have been greatly colored by findings that some of them have been endowed with the self-renewal trait associated with no...
Source
Cited By18
Newest
Cancer stem cells (CSCs) refer to a certain subpopulation within the tumor entity that is characterized by restricted cellular proliferation and multipotent differentiation potency. The existence of CSCs has been proven to contribute to the heterogeneity of malignancies, accounting for intensified tumorigenesis, treatment resistance, and metastatic spread. Dormancy was proposed as a reversible state of cancer cells that are temporarily arrested in the cell cycle, possessing several hallmarks tha...
Source
#1Andrew SulaimanH-Index: 8
#2Sarah McGarryH-Index: 13
view all 5 authors...
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that disproportionally accounts for the majority of breast cancer-related deaths due to the lack of specific targets for effective treatments. In this review, we highlight the complexity of the transforming growth factor-beta family (TGF-β) pathway and discuss how the dysregulation of the TGF-β pathway promotes oncogenic attributes in TNBC, which negatively affects patient prognosis. Moreover, we discuss recent findings highlight...
Source
#1Juan Wang (Qingdao University)H-Index: 1
#2Zhonghang Xu (JLU: Jilin University)
Last. Li-Min Lun (Qingdao University)H-Index: 11
view all 5 authors...
Transforming growth factor beta (TGF-β) plays key roles in regulating cellular proliferation and maintaining tissue homeostasis. TGF-β exerts tumor-suppressive effects in the early stages of carcinogenesis, but it also plays tumor-promoting roles in established tumors. Additionally, it plays a critical role in cancer radiotherapy. TGF-β expression or activation increases in irradiated tissues, and studies have shown that TGF-β plays dual roles in cancer radiosensitivity and is involved in ionizi...
Source
#1Haonan LiH-Index: 1
#2Guohui Wang (Hebei Medical University)
Last. Xiaoying XueH-Index: 1
view all 10 authors...
Source
#1Poonam Yadav (HBNI: Homi Bhabha National Institute)H-Index: 1
#2Vipul K. Pandey (BARC: Bhabha Atomic Research Centre)H-Index: 4
Last. Bhavani S. Shankar (HBNI: Homi Bhabha National Institute)H-Index: 12
view all 3 authors...
Our previous studies have shown that MCF-7 breast cancer cell line exposed to 6 Gy and allowed to recover for 7 days (D7-6G) developed radio-resistance. In this study, we have tested the ability of these cells to form tumors in severe combined immunodeficiency (SCID) mice and characterized these tumors by proteomic analyses. Untreated (MCF-C) and D7-6G cells (MCF-R) were injected s.c. in SCID mice and tumor growth monitored. On Day 18, the mice were killed and tumor tissues were fixed in formali...
Source
#1Weili MiaoH-Index: 14
#2David BadeH-Index: 2
Last. Yinsheng WangH-Index: 63
view all 3 authors...
Radiotherapy constitutes a major therapeutic modality for early management of breast cancer. Despite the high efficacy in treating breast cancer (BC), radiation resistance and tumor recurrence are major hurdles in breast cancer radiotherapy. Herein, stable isotope labeling by amino acids in cell culture (SILAC) was employed, along with the parallel-reaction monitoring (PRM)-based targeted quantitative proteomic method, to examine the differences in kinase protein expression in MCF-7 and MDA-MB-2...
Source
#1Bin Yuan (University of Texas MD Anderson Cancer Center)H-Index: 13
#2Fouad El Dana (University of Texas MD Anderson Cancer Center)H-Index: 1
Last. Venkata Lokesh Battula (University of Texas MD Anderson Cancer Center)H-Index: 11
view all 9 authors...
The bone marrow microenvironment (BME) in acute myeloid leukemia (AML) consists of various cell types that support the growth of AML cells and protect them from chemotherapy. Mesenchymal stromal cells (MSCs) in the BME have been shown to contribute immensely to leukemogenesis and chemotherapy resistance in AML cells. However, the mechanism of stroma-induced chemotherapy resistance is not known. Here, we hypothesized that stromal cells promote a stem-like phenotype in AML cells, thereby inducing ...
Source
Breast cancer is the second leading cause of cancer-related death in women and is a complex disease with high intratumoral and intertumoral heterogeneity. Such heterogeneity is a major driving force behind failure of current therapies and development of resistance. Due to the limitations of conventional therapies and inevitable emergence of acquired drug resistance (chemo and endocrine) as well as radio resistance, it is essential to design novel therapeutic strategies to improve the prognosis f...
Source
#1Rui WangH-Index: 2
#2Jun ShenH-Index: 2
Last. Jun ZhouH-Index: 2
view all 7 authors...
Disulfiram (DSF), also known as "Antabuse", has been widely used in clinical practice to treat alcoholism. In the past decades, both in vivo and in vitro experiments showed that DSF has strong anti-cancer activity, there were some clinical studies indicated the administration of this drug was associated with favorable survival in breast cancer. It is also evident that DSF has a radioprotective effect on normal cells and could be utilized during the course of radiation therapy. Moreover, increasi...
Source
#1Kyung Hwan Kim (Yonsei University)H-Index: 35
#2Han Sang KimH-Index: 17
Last. Sun Young RhaH-Index: 75
view all 7 authors...
Background: Despite the important role of radiotherapy in cancer treatment, a subset of patients responds poorly to treatment majorly due to radioresistance. Particularly the role of radiotherapy has not been established in gastric cancer (GC). Herein, we aimed to identify a radiosensitivity gene signature and to discover relevant targets to enhance radiosensitivity in gastric cancer (GC) cells. Methods: An oligonucleotide microarray (containing 22,740 probes) was performed in 12 GC cell lines p...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.